ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2021
Norrish' type I and II reactions and their role in the building of photochemical science.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Unified Total Synthesis ofJournal of the American Chemical Society · 2025Article
- Photoreactivity of Norrish Type Photoinitiators for 3D Laser Printing via First Principles Calculations.Macromolecular rapid communications · 2025Article
- Deacylative Homolysis of Ketone C(spJournal of the American Chemical Society · 2025Article
- [2+2]-Photocycloadditions of 1,4-Naphthoquinone Under Batch and Continuous-Flow Conditions.Molecules (Basel, Switzerland) · 2024Article
- Antimicrobial properties of hindered amine light stabilizers in polymer coating materials and their mechanism of action.Frontiers in bioengineering and biotechnology · 2024Article
- Blue-to-UVB Upconversion, Solvent Sensitization and Challenging Bond Activation Enabled by a Benzene-Based Annihilator.Angewandte Chemie (International ed. in English) · 2023Article
- A Photochemical Macrocyclization Route to Asymmetric Strained [3.2] Paracyclophanes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022Article
- Enhanced thermal and photo-stability of aFrontiers in chemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The highly inspiring work by Professor Norrish has exerted a consistent influence on chemistry and, in particular, on photochemistry, where he was one of the first scientists, along with Gilbert N. Lewis, able to develop a viable concept of excited states and their rate of reaction. However, having him listed among the authors of two name reactions, known as Norrish Type I and Type II, plus a subcase of the latter that is the Yang cyclization, is not coherent. Indeed, Norrish had no interest in organic synthesis, while this is a required feature of name reactions. And, at any rate, Professors Ciamician and Paternò had arrived at the same conclusions with the same compounds much earlier, except for the measurement of quantum yields. Things are too long away now for introducing any change, but one should remember that using Norrish name here is a mistake, while it would be appropriate to add the name of Ciamician for a different name reaction, the 2 + 2 cycloaddition of alkenes and conjugated carbonyls. In 1968, such an attribution was proposed by Professor Schömberg, but this had no effect and the present assignment has become a habit. The most important thing, however, is that the 2 + 2 reaction has become one of the most popular reactions in synthetic photochemistry.
Identifiers
33721236What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.